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background: Total contrast volume (CV) use during endovascular therapy (EVT) is a potential risk factor for acute kidney injury but has 
not been well studied in this context. The purpose of this analysis was to define the range of CV used for infrainguinal EVT by anatomic 
location, lesion type, and treatment strategy. The multivariable predictors for increased CV use were assessed.
methods: Data on EVT cases between 2005 and 2014 were obtained from the XLPAD dataset and consisted of: patient demographics, 
clinical variables, lesion characteristics, and treatment strategies. Predictors of CV > median were defined.
results: 909 EVT cases were analyzed in 640 patients. 81.6% were male, 56.4% were diabetic, 19.3% had CKD, 74.6% had claudication 
and 25.4% had CLI. 70.1% of cases were above the knee, 14.4% were below the knee, and 15.5% were multi-level. 55.6% were chronic 
total occlusions (CTOs). 37.4% underwent atherectomy, 59.5% stenting, and 18.5% angioplasty. Median CV was 160 ml (10-585). 
Multivariate predictors (P<0.05) of CV >160 ml, included female gender, multilevel disease, CAD, lesion length > 110 mm, and use of 
atherectomy. While the presence of a CTO was not predictive of increased CV, the use of a CTO crossing device (P<0.001) or re-entry 
device (p<0.001) was predictive. See Figure 1.
Conclusion:  Female gender is associated with higher CV use. Lesion/vessel length, lesion complexity requiring CTO crossing devices or 
re-entry increase CV use. Atherectomy may also be associated with higher CV administration.
 
